TAIWAN · TWSE / TPEx
BioGend
博晟生醫 · 6733 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$23.801 month -5.0% · 1 year -40.2%
Directors and supervisors hold49,156,24336.6% of shares issued
Of which pledged10.2%5,000,000
Major shareholders (10%+) hold45,232,24333.7% of shares issued
Revenue, 2026-09+9.5%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 陳德禮 | Chairman · President | 3,790,000 | 3,840,000 | 2.86% | — | 700,000 |
| 林榮錦 | Director | — | 0 | — | — | 650,079 |
| 晟德大藥廠股份有限公司 | Director · Major shareholder (10%+) | 37,580,008 | 45,232,243 | 33.68% | 5,000,000 | — |
| 王素琦 | Director (corporate representative) | — | 0 | — | — | — |
| 曾厚 | Independent director | — | 0 | — | — | — |
| 張峰義 | Independent director | — | 0 | — | — | — |
| 許惠恒 | Independent director | 30,000 | 84,000 | 0.06% | — | 55,000 |
| 林于聖 | Independent director | — | 0 | — | — | — |
| 張博智 | Assistant vice president | — | 200,000 | 0.15% | — | — |
| 李伯偉 | Assistant vice president | — | 218,018 | 0.16% | — | — |
| 張桂芬 | Assistant vice president | — | 329,290 | 0.25% | — | — |
| 趙叔威 | Chief financial officer | — | 100,000 | 0.07% | — | — |
| 李英綺 | Chief accountant | — | 125,000 | 0.09% | — | 71,000 |